Delivery Method: VIA Electronic Mail Product: Drugs Recipient: Recipient Name Mr. Ankur J. Shah Recipient Title President Velocity Pharma LLC 26 Blueberry Ct.Melville, NY 11747United States […]

The FDA Compounding Quality Center of Excellence provides training anytime, anywhere at no cost. Each course provides continuing education (CE) credits for pharmacists, pharmacy technicians, physicians […]

37. NexoBrid anacaulase-bcdb 12/28/2022 To remove eschar in adults with deep partial thickness or full thickness thermal burnsDrug Trials Snapshot 36. Briumvi ublituximab-xiiy 12/28/2022 To treat […]

FDA recognizes that there is much that is not known scientifically about kratom. Although there are published animal studies with kratom extracts containing mitragynine or 7-OH-mitragynine, […]

For Immediate Release: August 02, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the […]

On August 2, 2024, the Food and Drug Administration granted accelerated approval to afamitresgene autoleucel (TECELRA, Adaptimmune, LLC), a melanoma-associated antigen A4 (MAGE-A4)-directed genetically modified autologous […]

Español 药物安全通讯 Drug Safety Podcast 01-11-2024 FDA Drug Safety Communication Drug Safety Communication (PDF – 214 KB) The U.S. Food and Drug Administration (FDA) has been evaluating reports […]

Image By: Christine Lee, Acting Associate Commissioner for Minority Health, Office of Minority Health and Health Equity In late June, representatives of the U.S. Food and […]

FDA has reevaluated the rationale document titled, “Daptomycin Breakpoints for Enterococci,” submitted by the Clinical and Laboratory Standards Institute (CLSI) to FDA public docket # FDA-2017-N-5925-020 […]